AN2 Therapeutics (NASDAQ:ANTX) reported quarterly losses of $(0.59) per share. This is a 82.39 percent increase over losses of $(3.35) per share from the same period last year.
Dogecoin Spikes, Bitcoin, Ethereum Drop While Vitalik Buterin Raises Concerns Around WorldCoin: Analyst Predicts $100K Mark For King Crypto After 50% Drop
Major cryptocurrencies traded in a mixed manner on Monday evening, amid speculation surrounding a potential U.S. regulator appeal in the Ripple case and a decline in enthusiasm towards a Bitcoin ETF.
